Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.53 - $10.84 $2.05 Million - $4.02 Million
-370,760 Reduced 96.93%
11,747 $123,000
Q1 2022

May 16, 2022

BUY
$6.11 - $9.34 $1.14 Million - $1.75 Million
187,055 Added 95.7%
382,507 $3.38 Million
Q4 2021

Feb 14, 2022

BUY
$6.74 - $22.31 $1.24 Million - $4.09 Million
183,405 Added 1522.41%
195,452 $1.35 Million
Q3 2021

Nov 15, 2021

BUY
$12.03 - $18.25 $144,925 - $219,857
12,047 New
12,047 $150,000
Q2 2021

Aug 13, 2021

SELL
$18.09 - $22.42 $462,543 - $573,256
-25,569 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$18.17 - $25.77 $464,588 - $658,913
25,569 New
25,569 $534,000
Q4 2020

Feb 16, 2021

SELL
$11.33 - $19.55 $1.2 Million - $2.07 Million
-105,641 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$10.8 - $14.17 $2.5 Million - $3.28 Million
-231,693 Reduced 68.68%
105,641 $1.2 Million
Q2 2020

Aug 13, 2020

BUY
$11.85 - $17.47 $918,884 - $1.35 Million
77,543 Added 29.85%
337,334 $4.6 Million
Q1 2020

May 15, 2020

BUY
$10.32 - $21.06 $2.52 Million - $5.15 Million
244,321 Added 1579.32%
259,791 $3.38 Million
Q4 2019

Feb 14, 2020

BUY
$20.16 - $29.69 $311,875 - $459,304
15,470 New
15,470 $312,000
Q2 2019

Aug 14, 2019

SELL
$19.6 - $24.45 $364,207 - $454,329
-18,582 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$15.77 - $19.94 $293,038 - $370,525
18,582 New
18,582 $371,000
Q4 2018

Feb 14, 2019

SELL
$13.35 - $20.11 $1.91 Million - $2.87 Million
-142,836 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$17.19 - $30.52 $2.46 Million - $4.36 Million
142,836 New
142,836 $2.54 Million

About Radius Health, Inc.


  • Ticker RDUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 47,620,500
  • Market Cap $480M
More about RDUS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.